Hasil Pencarian - Marcin Stajszczyk

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study

    Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the... oleh Marcin Stajszczyk, Sławomir Jeka, Anna Juś, Katarzyna Pawlak-Buś

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The perspective of Polish patients with rheumatoid arthritis – treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study)

    The perspective of Polish patients with rheumatoid arthritis – treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study) oleh Marcin Stajszczyk, Grażyna Świerkowska, Katarzyna Smolik, Izabela Domysławska, Karol Charkiewicz, Włodzimierz Samborski

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study

    Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study oleh Bogdan Batko, Marcin Stajszczyk, Jerzy Świerkot, Karol Urbański, Filip Raciborski, Mariusz Jędrzejewski, Piotr Wiland

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion

    COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion oleh Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Żuber, Krzysztof Tomasiewicz

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis – why cardiovascular risk factors do not equate to overt risk

    Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis – why cardiovascular risk factors do not equate to overt risk oleh Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance

    Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance oleh Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk, Magdalena Kosydar-Piechna, Mary Jane Cadatal, Jose L. Rivas

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Adult pneumococcal vaccination – new opportunities

    Adult pneumococcal vaccination – new opportunities oleh ERNEST KUCHAR, JOANNA CHOROSTOWSKA-WYNIMKO, LESZEK CZUPRYNIAK, ANDRZEJ FAL, ROBERT FLISIAK, ARTUR MAMCARZ, ANETA NITSCH-OSUCH, ANNA SKOCZYŃSKA, MARCIN STAJSZCZYK, JACEK WYSOCKI, MICHAŁ ABENDROT, DOMINIK GOLICKI, KATARZYNA JAŚKOWIAK, ADAM ANTCZAK

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: